Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000346631

Medchemexpress LLC Velagliflozin proline | 1539295-26-5 | 99.4% | 510.58 | 1 ML
SDP

Catalog No. 5000346631
Encompass_Preferred

Velagliflozin proline is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor that exhibits antidiabetic activity. It functions by decreasing renal glucose reabsorption and promoting glycosuria, which consequently leads to a reduction in blood sugar and insulin concentrations.

  • Increases cholesterol, albumin, beta-hydroxybutyrate, nonesterified fatty acids, and urinary glucose excretion.
  • Decreases respiratory exchange ratio.
  • Is well tolerated.
  • Can improve insulin disorders.
  • Prevents laminitis by reducing the high insulin response of dietary non-structural carbohydrates.

Catalog No. 50-003-46631 Supplier Medchemexpress LLC Supplier No. HY109018A10MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Velagliflozin proline is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor that exhibits antidiabetic activity. It functions by decreasing renal glucose reabsorption and promoting glycosuria, which consequently leads to a reduction in blood sugar and insulin concentrations.

  • Increases cholesterol, albumin, beta-hydroxybutyrate, nonesterified fatty acids, and urinary glucose excretion.
  • Decreases respiratory exchange ratio.
  • Is well tolerated.
  • Can improve insulin disorders.
  • Prevents laminitis by reducing the high insulin response of dietary non-structural carbohydrates.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.